Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Neutrophil subpopulation-specific ratio and neutrophil extracellular traps are dynamic and sensitive biomarkers of thrombo-inflammation in patients with acute coronary syndrome – a prospective study

Shirly Partouche, Roy Hershenson, Idan Goldberg, Tarek Assali, Tsahi Lerman, Ran Kornowski, Pia Raanani, Galit Granot, Ofir Wolach, Alon Eisen

Blood (2025) 146 (Supplement 1): 1217.

https://doi.org/10.1182/blood-2025-1217

Published: 2025

Journal Articles

Factors associated with clinically significant systemic methotrexate absorption following intrathecal methotrexate administration - a prospective Study

Bahaa Atamna, Alon Rozental, Pia Raanani, Moshe Yeshurun, Ofir Wolach

Blood (2025) 146 (Supplement 1): 6826.

https://doi.org/10.1182/blood-2025-6826

Published: 2025

Journal Articles

G6PD-deficiency is associated with improved survival in patients with AML treated with venetoclax and azacitidine

Shira Buchrits, Alon Rozental, Ofer Algor, Shirly Partouche, Galit Granot, Pia Raanani, Ofir Wolach

Blood (2025) 146 (Supplement 1): 6993.

https://doi.org/10.1182/blood-2025-6993

Published: 2025

Journal Articles

Revumenib for patients with relapsed or refractory (R/R) Nucleophosmin 1–Mutated (NPM1m) Acute Myeloid Leukemia (AML): Outcomes by prior treatment in the phase 2 AUGMENT-101 study

Blood (2025) 146 (Supplement 1): 3418.

https://doi.org/10.1182/blood-2025-3418

Published: 2025

Journal Articles

Subclinical cardiac changes following CPX-351 induction in adults with favorable/intermediate-risk AML

Chezi Ganzel, Avraham Frisch, Ofir Wolach, Yakir Moshe, Baher Krayem, Neta Dor, Jacob Rowe, Yishai Ofran

Blood (2025) 146 (Supplement 1): 5239.

https://doi.org/10.1182/blood-2025-5239

Published: 2025

Journal Articles

Disease status at initiation of blinatumomab and depth of response after cycle 1 are associated with survival in Philadelphia chromosome positive B cell acute lymphoblastic leukemia patients treated with blinatumomab and tyrosine kinase inhibitors

Ori Grossberger, Adi Sherban, Irina Amitai, Ilana Hellmann, Boaz Nachmias, Ofir Wolach, Yakir Moshe

Blood (2025) 146 (Supplement 1): 3321.

https://doi.org/10.1182/blood-2025-3321

Published: 2025

Journal Articles

Cladribine-based regimens for Relapsed/Refractory Acute Myeloid Leukemia – a real-world multicenter retrospective study

Liat Shargian, Maya Zlotnick, Ron Ram, Odelia Amit, Adi Sherban, Ofir Wolach, Adi Schacham Abulafia, Boaz Nachmias, Chezi Ganzel, Drorit Merkel, Meirav Kedmi, Abraham Avigdor, Irina Amitai

Blood (2025) 146 (Supplement 1): 6969.

https://doi.org/10.1182/blood-2025-6969

Published: 2025

Journal Articles

ICE therapy for primary and secondary central nervous system involvement of lymphomas

Nasrin Dahamsha, Alon Rozental, Pia Raanani, Ronit Gurion, Ofir Wolach

Blood (2025) 146 (Supplement 1): 3701.

https://doi.org/10.1182/blood-2025-3701

Published: 2025

Journal Articles

Menin inhibition with revumenib for NPM1 -mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

Blood (2025) 146 (9): 1065–1077.

https://doi.org/10.1182/blood.2025028357

Published: 2025

Includes: Supplemental data

Journal Articles

Interferon Inhibits Netosis in Neutrophils Derived from Patients with Myeloproliferative Neoplasms in a Neutrophil Subpopulation-Specific Manner

Idan Goldberg, Shirly Partouche, Erez Halperin, Bahaa Atamna, Adi Shacham Abulafia, Saar Shapira, Aladin Samara, Ayala Gover-Proaktor, Avi Leader, Galia Spectre, Pia Raanani, Galit Granot, Ofir Wolach

Blood (2024) 144 (Supplement 1): 1762.

https://doi.org/10.1182/blood-2024-209795

Published: 2024

Journal Articles

Phase II Prospective Trial of Fixed Duration Obinutuzumab, Ibrutinib and, Venetoclax in an Elderly Cohort of Patients with Richter's Syndrome-Givers Regimen

Tamar Tadmor, Ohad Benjamini, Neta Goldschmidt, Natalia Kreiniz, Osnat Bairey, Reut Harel, Nadav Sarid, Tsofia Levi, Ofir Wolach, Yair Herishanu

Blood (2024) 144 (Supplement 1): 1862.

https://doi.org/10.1182/blood-2024-205236

Published: 2024

Journal Articles

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy

Blood (2024) 144 (Supplement 1): 1250.

https://doi.org/10.1182/blood-2024-201997

Published: 2024

Journal Articles

Warburg-Effect Driven Lactic Acidosis Is Associated with Early Death in Patients with Lymphoma

Bahaa Atamna, Alon Rozental, Mohamed Haj Yahia, Ronit Gurion, Moshe Yeshurun, Pia Raanani, Ofir Wolach

Blood (2024) 144 (Supplement 1): 4476.

https://doi.org/10.1182/blood-2024-208234

Published: 2024

Journal Articles

Genotype-phenotype correlations in chronic granulomatous disease: insights from a large national cohort

Blood (2024) 144 (12): 1300–1313.

https://doi.org/10.1182/blood.2023022590

Published: 2024

Includes: Supplemental data

Journal Articles

Gilteritinib and Venetoclax for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia - a Real-World Multicenter Retrospective Study

Eitan Kugler, Inbar Cohen, Ron Ram, Jonathan Canaani, Irina Amitai, Liat Shargian, Boaz Nachmias, Baher Krayem, Avraham Frisch, Itay Levi, Luiza Akria, Pia Raanani, Ofir Wolach, Eitan Kugler

Blood (2023) 142 (Supplement 1): 5911.

https://doi.org/10.1182/blood-2023-185488

Published: 2023

Journal Articles

Warburg-Effect Driven Lactic Acidosis Is Associated with Early Death in Patients with Lymphoma

Bahaa Atamna, Pia Raanani, Ronit Gurion, Ofir Wolach

Blood (2023) 142 (Supplement 1): 6307.

https://doi.org/10.1182/blood-2023-187265

Published: 2023

Journal Articles

Utility of Echocardiogram in Neutropenic Patients with Gram Positive Bacteremia: A Retrospective Study

Neta Sternbach, Pia Raanani, Dafna Yahav, Liat Shragian, Moshe Yeshurun, Ofir Wolach, Haim Ben zvi

Blood (2023) 142 (Supplement 1): 5830.

https://doi.org/10.1182/blood-2023-178346

Published: 2023

Journal Articles

Efficacy of Luspatercept in Low-Risk Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

Irina Amitai, Ronit Gurion, Pia Raanani, Moshe Yeshurun, Ofir Wolach, Drorit Merkel, Yoav Amitai, Anat Gafter-Gvili, Liat Shargian

Blood (2023) 142 (Supplement 1): 6487.

https://doi.org/10.1182/blood-2023-189891

Published: 2023

Journal Articles

Unraveling the Mechanism of Action of Bispecific T-Cell Engagers in B-Cell Acute Lymphoblastic Leukemia Using Advanced Single-Cell Multiomics

Anna Gurevich Shapiro, Eitan Winter, Yakir Moshe, Yonatan Katzenelenbogen, Diego Jaitin, Mor Zada, Oren Barboy, Ido Yofe, Paulina Chalan, San Truong Phan, Amir Giladi, Michael Shapiro, Renana Robinson, Eitan Kugler, Ofir Wolach, Irit Avivi Mazza, Ido Amit

Blood (2023) 142 (Supplement 1): 599.

https://doi.org/10.1182/blood-2023-188930

Published: 2023

Journal Articles

Daunorubicin/Cytarabine Liposome +/- Gemtuzumab Ozogamicin for Adult Patients with Newly Diagnosed, Low-Intermediate Risk, FLT3-Wild Type, AML: A Pilot Study

Chezi Ganzel, Avraham Frisch, Ofir Wolach, Yakir Moshe, Ellen Broide, Emmanuel Benayoun, Jacob M. Rowe, Yishai Ofran

Blood (2023) 142 (Supplement 1): 2892.

https://doi.org/10.1182/blood-2023-185052

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Neutrophil subpopulation-specific ratio and neutrophil extracellular traps are dynamic and sensitive biomarkers of thrombo-inflammation in patients with acute coronary syndrome – a prospective study

Factors associated with clinically significant systemic methotrexate absorption following intrathecal methotrexate administration - a prospective Study

G6PD-deficiency is associated with improved survival in patients with AML treated with venetoclax and azacitidine

Revumenib for patients with relapsed or refractory (R/R) Nucleophosmin 1–Mutated (NPM1m) Acute Myeloid Leukemia (AML): Outcomes by prior treatment in the phase 2 AUGMENT-101 study

Subclinical cardiac changes following CPX-351 induction in adults with favorable/intermediate-risk AML

Disease status at initiation of blinatumomab and depth of response after cycle 1 are associated with survival in Philadelphia chromosome positive B cell acute lymphoblastic leukemia patients treated with blinatumomab and tyrosine kinase inhibitors

Cladribine-based regimens for Relapsed/Refractory Acute Myeloid Leukemia – a real-world multicenter retrospective study

ICE therapy for primary and secondary central nervous system involvement of lymphomas

Menin inhibition with revumenib for NPM1 -mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

Interferon Inhibits Netosis in Neutrophils Derived from Patients with Myeloproliferative Neoplasms in a Neutrophil Subpopulation-Specific Manner

Phase II Prospective Trial of Fixed Duration Obinutuzumab, Ibrutinib and, Venetoclax in an Elderly Cohort of Patients with Richter's Syndrome-Givers Regimen

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy

Warburg-Effect Driven Lactic Acidosis Is Associated with Early Death in Patients with Lymphoma

Genotype-phenotype correlations in chronic granulomatous disease: insights from a large national cohort

Gilteritinib and Venetoclax for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia - a Real-World Multicenter Retrospective Study

Warburg-Effect Driven Lactic Acidosis Is Associated with Early Death in Patients with Lymphoma

Utility of Echocardiogram in Neutropenic Patients with Gram Positive Bacteremia: A Retrospective Study

Efficacy of Luspatercept in Low-Risk Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

Unraveling the Mechanism of Action of Bispecific T-Cell Engagers in B-Cell Acute Lymphoblastic Leukemia Using Advanced Single-Cell Multiomics

Daunorubicin/Cytarabine Liposome +/- Gemtuzumab Ozogamicin for Adult Patients with Newly Diagnosed, Low-Intermediate Risk, FLT3-Wild Type, AML: A Pilot Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only